Sat.Aug 27, 2022 - Fri.Sep 02, 2022

Psychedelic clinical trials: What sponsors should know when designing new protocols

Bio Pharma Dive

With regulators and lawmakers seemingly on board, sponsors have more opportunities than ever to pursue clinical research in this high-velocity area

The futility of banner ads

World of DTC Marketing

Digital ad spending in the industry will reach $15.84 billion in 2022. Although growth in digital budgets is slowing, we estimate the category will see nearly $20 billion in spending in 2024.


Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

Novo Nordisk agrees to acquire biopharma firm Forma for $1.1bn

Pharmaceutical Technology

Novo Nordisk has signed a definitive agreement for the acquisition of clinical-stage biopharmaceutical firm Forma Therapeutics for $20 for each share in cash or a total equity price of $1.1bn.

How to Start a Pharma Company with a Low Budget in India?

Fossil Remedies

Do you think that India is a great place to launch a pharma business? Yes, indeed it is. In the past few decades, the Indian economy has done remarkably well. Many sectors have performed well, and the pharma sector is one of them. And the journey of growth has not ended yet.

2022 Research: The Rapid Rise of Ocean Freight Visibility

Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.

Sangamo presses ahead with Fabry disease gene therapy

Bio Pharma Dive

Preliminary results from a Phase 1 study show Sangamo’s treatment to be safe and suggest it is working as intended, leading the biotech to move into the trial’s next phase

DTC as part of an integrated strategy

World of DTC Marketing

DTC marketers spend a lot of time and money gaining insights into patients and caregivers. That information should be shared with HCPs and insurers to understand better the barriers and opportunities of treating patients.

More Trending

Arcturus announces $63m award from US government to support development of self-amplifying mRNA vaccine

BioPharma Reporter

Arcturus Therapeutics has obtained an award for up to $63.2m

Biotech startup Ocean pivots from IPO to SPAC merger

Bio Pharma Dive

The blank-check deal gives Ocean another route to public markets after it struggled to price an initial public offering it revealed back in June 2021

Life expectancy declines again

World of DTC Marketing

According to STAT News, “Americans born in 2021 can expect to live for just 76.1 years — the lowest life expectancy has been since 1996, according to a new government analysis published Wednesday. This is the biggest two-year decline — 2.7 years in total — in almost 100 years.”

FDA grants EUAs for Moderna and Pfizer-BioNTech’s bivalent Covid-19 boosters

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has granted Emergency Use Authorizations (EUAs) for bivalent formulations of Moderna and Pfizer -BioNTech’s Covid-19 vaccines as boosters.

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.

European Commission grants marketing authorization for Ranivisio?®* (ranibizumab), a biosimilar to Lucentis®**, for age-related macular degeneration (AMD) 

The Pharma Data

Teva Pharmaceuticals to commercialize the product in Europe. Age-related macular degeneration (AMD) affects around 67 million people in Europe and is a leading cause of blindness for working age adults with uncontrolled diabetes 1 and the most common cause of blindness in developed countries 2.

Atlas Venture’s Bruce Booth on testing the IPO waters and putting the ‘tech’ in biotech

Bio Pharma Dive

In a wide-ranging conversation with BioPharma Dive, Booth, a prolific builder of new biotechs, said he’s starting to see positive signs for startups considering an IPO or private financing


SaNOtize bags $24M to fund phase 3 trial of COVID-19 nasal spray

Fierce Pharma

SaNOtize bags $24M to fund phase 3 trial of COVID-19 nasal spray. ntaylor. Tue, 08/30/2022 - 09:49

Trials 108

Rankings: Business Expansion

Pharmaceutical Technology

The Excellence Rankings celebrate the greatest achievements and innovations in the industry. The programme provides a platform to recognise the people and companies that are driving change.

Mandatory COVID Vaccination Policy Template

The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.

Kerendia™ (finerenone) receives updated label in the U.S. to include findings from Phase III FIGARO-DKD cardiovascular outcomes study

The Pharma Data

Beam details reasons for FDA hold on base editing cancer therapy

Bio Pharma Dive

The regulator has asked Beam for a range of technical data before it can start testing the blood cancer treatment in humans

AstraZeneca CEO Soriot questions value of annual COVID boosters in healthy people

Fierce Pharma

AstraZeneca CEO Soriot questions value of annual COVID boosters in healthy people. kdunleavy. Tue, 08/30/2022 - 11:28


Moderna files lawsuits against Pfizer and BioNTech over mRNA technology

Pharmaceutical Technology

Moderna has f iled patent infringement lawsuits in the US District Court for the District of Massachusetts and the Regional Court of Düsseldorf in Germany against Pfizer and BioNTech over messenger ribonucleic acid (mRNA) technology.

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union

The Pharma Data

CDC backs updated COVID shots from Pfizer, Moderna

Bio Pharma Dive

One day after the FDA’s authorization, the CDC recommended the companies’ omicron-targeted vaccines for most adults and children over 12 years old

Pfizer, Moderna bivalent COVID booster nods could land this week: report

Fierce Pharma

Pfizer, Moderna bivalent COVID booster nods could land this week: report. fkansteiner. Tue, 08/30/2022 - 09:05


Brazil: untapped market for big pharma manufacturing

Pharmaceutical Technology

International companies investing in the emerging market of Brazilian pharmaceutical manufacturing will see a higher return on investment than from developed market equivalents, if they choose to compete with local manufacturers to supply Brazil’s growing market and the greater South American region.

Research reveals widespread use of ineffective COVID-19 treatments after FDA deauthorized their use

The Pharma Data

Monoclonal antibodies are laboratory- designed treatments knitter- made to fight specific infections. In early 2021, theU.S.

Novartis’ Bradner steps down as research head amid company shake-up

Bio Pharma Dive

A well-known physician-scientist who joined Novartis from Harvard, Jay Bradner spent over six years steering the company’s research hub. He will be replaced by Merck executive Fiona Marshall

Boehringer Ingelheim finally has skin in the game, scoring its first dermatology FDA nod

Fierce Pharma

Boehringer Ingelheim finally has skin in the game, scoring its first dermatology FDA nod. kdunleavy. Fri, 09/02/2022 - 09:18

Novartis extends Kaiku digital patient monitoring partnership

Pharma Phorum

Kaiku Health’s year-old alliance with Novartis to develop a digital patient monitoring and management (DPPM) system for patients with melanoma is being extended, according to the two partners.

Drugs 94


The Pharma Data

LUMAKRAS Met Primary Endpoint of Progression-Free Survival, Demonstrating Superiority Over Standard of Care Docetaxel Chemotherapy, in KRAS G12C-Mutated Non-Small Cell Lung Cancer. Detailed Data to be Presented at an Upcoming Medical Congress.

Finch to lay off 37% of staff after Takeda ends microbiome drug deal

Bio Pharma Dive

The company will cut 50 full-time positions and halt preclinical work on a pill for symptoms of autism in its second restructuring effort since April

Drugs 232

Amid launch efforts, Neurocrine doles out £48M to acquire small UK biotech Diurnal

Fierce Pharma

Amid launch efforts, Neurocrine doles out £48M to acquire small UK biotech Diurnal. zbecker. Tue, 08/30/2022 - 11:01


Boehringer bags first approval for rare skin disease drug

Pharma Phorum

German drugmaker Boehringer Ingelheim has its first regulatory approval for spesolimab, its antibody therapy for rare and life-threatening skin disorder generalised pustular psoriasis (GPP), in the US.

Efficacy, cash and more will increase booster shot acceptance

The Pharma Data

The more effective the COVID- 19 supporter, the more likely people are to get it, according to new Cornell exploration. And they’re more likely to accept the supporter shot with cash impulses and if it’s made by Moderna or Pfizer.

With rare acquisition, Novo Nordisk makes $1B bet on sickle cell disease drug

Bio Pharma Dive

The target company, Forma Therapeutics, started as a developer of cancer drugs but has made the most progress in rare blood disorders, attracting Novo’s attention

Pfizer shifts oncology chief Schmeltz to new strategy role as rare disease head Varma fills in

Fierce Pharma

Pfizer shifts oncology chief Schmeltz to new strategy role as rare disease head Varma fills in. zbecker. Fri, 09/02/2022 - 10:33


Hungary will deploy Brainomix AI stroke software nationwide

Pharma Phorum

UK medtech company Brainomix has claimed its first national contract – from Hungary – for its artificial intelligence-based platform used to improve diagnosis and treatment of people with suspected stroke from medical images.